[1]
“P118 | Long term outcome and disease duration in patients treated with anti-IL 1 drugs for recurrent pericarditis: ad interim analysis of a longitudinal study: A. Pavarani1, E. Ceriani2, F. Agozzino1, P. Bindi1, S. Berra1, A. Brucato1, S. Macchi1, L. Vena1, F. Moda3 | 1Ospedale Fatebenefratelli, Milano, 2Ospedale Sacco, Milano, 3Ospedale Policlinico di Milano, Italy”, Ital J Med, vol. 19, no. 1(s1), Aug. 2025, doi: 10.4081/itjm.2025.2313.